Clinical Trial

Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study

Study acronym: RADIANT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 7, 2025 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The radiotherapy scheme with extreme hypofractionation has gained space in clinical practice and, therefore, it is necessary to analyze the Brazilian national experience in selected patients with breast cancer, with the aim of evaluating the oncological outcomes and toxicities with the use of this treatment protocol.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-03-08; most recent amendment 2025-03-06.
Status change: Not Yet Recruiting → Recruiting 2023-11-07
Trial Details
NCT Number NCT05776147
Lead Sponsor Latin American Cooperative Oncology Group
Conditions Radiotherapy Side Effect
Enrollment 400 participants
Start Date 2023-11-09
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-07